Life expectancy and cancer risk in patients with Barrett's esophagus: A prospective controlled investigation

American Journal of Medicine

Volumn 111, Issue 1, 2001, Pages 33-37

  Eckardt, Volker F ^a   Kanzler, Gerd ^b   Bernhard, Gudrun ^c  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^b Gastroenterologisches Institut Wiesbaden   (Germany)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASIA; ESOPHAGUS ACHALASIA; ESOPHAGUS CARCINOMA; ESOPHAGUS DISEASE; FEMALE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHATZKI RING; SURVIVAL RATE;

ADULT; AGED; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; CAUSE OF DEATH; ESOPHAGEAL DISEASES; ESOPHAGEAL NEOPLASMS; FEMALE; GERMANY; HUMANS; INCIDENCE; LIFE EXPECTANCY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; SURVIVAL RATE;

EID: 0034947031     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)00745-8     Document Type: Article

References (45)

1. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
2. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction
3. Adenocarcinoma in Barrett's esophagus: A new epidemic?
4. Changing trends in esophageal cancer: A 15-year experience in a single center
5. Incidence of Barrett's adenocarcinoma in an Italian population: An endoscopic surveillance programme
6. The incidence of adenocarcinoma in Barrett's esophagus: Prospective study of 170 patients followed for 4.8 years
7. Adenocarcinoma and Barrett's esophagus. An overrated risk?
8. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus
9. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus
10. Adenocarcinoma arising in Barrett's esophagus
11. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus
12. Barrett's esophagus: Development of dysplasia and adenocarcinoma
13. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus
14. Endoscopic surveillance of Barrett's esophagus: A cost-effectiveness comparison with mammographic surveillance for breast cancer
15. Effectiveness and patient satisfaction with nurse-directed treatment of Barrett's esophagus
16. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus
17. Cost effectiveness of detecting Barrett's cancer
18. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus
19. Barrett's esophagus. Prevalence and incidence of adenocarcinoma
20. Barrett's oesophagus in a university teaching hospital
21. Barrett's esophagus: Results of a multicentric survey
22. Length of Barrett's oesophagus: An important factor in the development of dysplasia and adenocarcinoma
23. Incidence of adenocarcinoma in Barrett's esophagus and an evaluation of endoscopic surveillance
24. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus. Report on the Cleveland Clinic Barrett's esophagus registry
25. Predictors of outcome in patients with achalasia treated by pneumatic dilation
26. Single dilation of symptomatic Schatzki Rings. A prospective evaluation of its effectiveness
27. Nonparametric estimation from incomplete observations
28. Is there publication bias in the reporting of cancer risk in Barrett's esophagus?
29. Adenocarcinoma in Barrett's oesophagus. An overrated risk
30. Adenocarcinoma of the lower esophagus. A disease primarily of white men with Barrett's esophagus
31. Adenocarcinoma of the esophagus and/or gastric cardia
32. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction
33. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus
34. Carcinoma arising in Barrett's esophagus
35. The results of surgery as first treatment for oesophageal cancer - A hospital based prospective study
36. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients
37. Endoscopic surveillance of Barrett's esophagus. Does it help?
38. The role of endoscopy in the surveillance of premalignant conditions of the upper gastrointestinal tract
39. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma
40. Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low- and high-risk patient subsets
41. Flow-cytometric, and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort
42. Barrett's esophagus: An overrated cancer risk factor
43. Barrett's oesophagus in a university teaching hospital
44. Appropriate use of gastrointestinal endoscopy